These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9607053)

  • 41. Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.
    Beck Y; Fritz R; Orlinger K; Kiermayr S; Ilk R; Portsmouth D; Pöllabauer EM; Löw-Baselli A; Hessel A; Kölch D; Howard MK; Barrett PN; Kreil TR
    J Virol; 2016 Feb; 90(4):1964-72. PubMed ID: 26656681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
    Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
    Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humoral and cellular immunity induced by antigens adjuvanted with colloidal iron hydroxide.
    Leibl H; Tomasits R; Brühl P; Kerschbaum A; Eibl MM; Mannhalter JW
    Vaccine; 1999 Mar; 17(9-10):1017-23. PubMed ID: 10195610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence estimation of tick-borne encephalitis virus (TBEV) antibodies in dogs from Finland using novel dog anti-TBEV IgG MAb-capture and IgG immunofluorescence assays based on recombinant TBEV subviral particles.
    Levanov L; Vera CP; Vapalahti O
    Ticks Tick Borne Dis; 2016 Jul; 7(5):979-982. PubMed ID: 27189583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Age affects quantity but not quality of antibody responses after vaccination with an inactivated flavivirus vaccine against tick-borne encephalitis.
    Stiasny K; Aberle JH; Keller M; Grubeck-Loebenstein B; Heinz FX
    PLoS One; 2012; 7(3):e34145. PubMed ID: 22461903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A comparison of the protective properties of preparations of the virion and nonvirion ("soluble") antigens of the tick-borne encephalitis virus].
    Liapustin VN; Pivanova GP; Karavanov AS; Lashkevich VA
    Vopr Virusol; 1991; 36(6):498-500. PubMed ID: 1785186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [A cultured concentrated inactivated vaccine against tick-borne encephalitis studied during the immunization of children and adolescents].
    Pavlova LI; Gorbunov MA; Vorob'eva MS; Karavanov AS; Grachev VP; Ladyshenskaia IP; Rasshchepkina MN; Mel'nikova LN; Lebedeva TM; Mel'nikov NA; Gusmanova AG; Deviatkov MIu; Rozanova EV; Mukachev MA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):50-3. PubMed ID: 10876850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunological indices of human vaccination against tick-borne encephalitis using inactivated preparations with a varying concentration of the viral antigen].
    El'bert LB; Pervikov IuV; Krutianskaia GL; Krasil'nikov IV; Grachev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Jun; (6):89-92. PubMed ID: 7293574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Different immune responses after intradermal and intramuscular administration of vaccine against tick-borne encephalitis virus.
    Zoulek G; Roggendorf M; Deinhardt F; Kunz C
    J Med Virol; 1986 May; 19(1):55-61. PubMed ID: 3701303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.
    Aberle JH; Schwaiger J; Aberle SW; Stiasny K; Scheinost O; Kundi M; Chmelik V; Heinz FX
    PLoS One; 2015; 10(10):e0140545. PubMed ID: 26465323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in the reproduction of tick-borne encephalitis virus in cell cultures].
    Morozova OV; Grishechkin AE; Bakhvalova VN; Isaeva EI; Podcherniaeva RIa
    Vopr Virusol; 2012; 57(2):40-3. PubMed ID: 22834147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Persistence of the tick-borne encephalitis virus in the vaccinated organism].
    Levina LS; Pogodina VV
    Vopr Virusol; 1988; 33(4):485-90. PubMed ID: 3195146
    [No Abstract]   [Full Text] [Related]  

  • 54. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human plasmacytoid dendritic cells at the crossroad of type I interferon-regulated B cell differentiation and antiviral response to tick-borne encephalitis virus.
    Etna MP; Signorazzi A; Ricci D; Severa M; Rizzo F; Giacomini E; Gaggioli A; Bekeredjian-Ding I; Huckriede A; Coccia EM
    PLoS Pathog; 2021 Apr; 17(4):e1009505. PubMed ID: 33857267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diminished response to tick-borne encephalitis vaccination in thymectomized children.
    Prelog M; Wilk C; Keller M; Karall T; Orth D; Geiger R; Walder G; Laufer G; Cottogni M; Zimmerhackl Lothar B; Stein J; Grubeck-Loebenstein B; Wuerzner R
    Vaccine; 2008 Jan; 26(5):595-600. PubMed ID: 18178293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
    Morozova OV; Maksimova TG; Bakhvalova VN
    Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Combined effects of immunomodulators and specific inactivated vaccines against alpha- and flavivirus infections].
    Barinskiĭ IF; Lazarenko AA; Alimbarova LM; Davydova AA
    Med Parazitol (Mosk); 2011; (1):17-20. PubMed ID: 21480553
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transcriptional Immunoprofiling at the Tick-Virus-Host Interface during Early Stages of Tick-Borne Encephalitis Virus Transmission.
    Thangamani S; Hermance ME; Santos RI; Slovak M; Heinze D; Widen SG; Kazimirova M
    Front Cell Infect Microbiol; 2017; 7():494. PubMed ID: 29250492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.